MetaADEDB 2.0 @ LMMD
eprosartan
(DJSLTDBPKHORNY-XMMWENQYSA-N)
Structure
SMILES
CS(=O)(=O)O.CCCCc1ncc(n1Cc1ccc(cc1)C(=O)O)/C=C(/C(=O)O)\Cc1cccs1
Molecular Formula:
C24H28N2O7S2
Molecular Weight:
520.618
Log P:
5.3292
Hydrogen Bond Acceptor:
10
Hydrogen Bond Donor:
3
TPSA:
183.41
CAS Number(s):
144143-96-4
Synonym(s)
1.
eprosartan
2.
SK&F 108566
3.
SKF-108566
4.
Teveten
External Link(s)
MeSHC068373
PubChem Compound5282474
ChEBI48409
CHEMBLCHEMBL1200987
KEGGdr:D02082
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1Pulmonary EmbolismFAERS: 6US FAERS
2Cerebrovascular accidentFAERS: 5US FAERS
3Intestinal ObstructionFAERS: 5US FAERS
4Abdominal adhesionsFAERS: 4US FAERS
5FatigueFAERS: 4US FAERS
6NauseaFAERS: 4US FAERS
7OverdoseFAERS: 4US FAERS
8Suicide attemptFAERS: 4US FAERS
9AngioedemaFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
10AstheniaFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
11DizzinessFAERS: 3US FAERS
12Intentional misuseFAERS: 3US FAERS
13MyalgiaFAERS: 3US FAERS
14UrticariaFAERS: 3US FAERS
15VasculitisFAERS: 3US FAERS
16Vocal Cord ParalysisFAERS: 3US FAERS
17Aortic AneurysmFAERS: 2US FAERS
18Autonomic nervous system imbalanceFAERS: 2US FAERS
19Back PainFAERS: 2US FAERS
20Blood potassium decreasedFAERS: 2US FAERS
21CellulitisFAERS: 2US FAERS
22Chronic sinusitisFAERS: 2US FAERS
23DysphoniaFAERS: 2US FAERS
24IritisFAERS: 2US FAERS
25Medication ErrorFAERS: 2US FAERS
26Myocardial InfarctionFAERS: 2US FAERS
27Oropharyngeal painFAERS: 2US FAERS
28Pulmonary FibrosisFAERS: 2US FAERS
29Abdominal PainFAERS: 1US FAERS
30Abdominal cavity drainageFAERS: 1US FAERS
31Accidental exposureFAERS: 1US FAERS
32Acute Coronary SyndromeFAERS: 1US FAERS
33Acute myocardial infarctionFAERS: 1US FAERS
34Acute psychosisFAERS: 1US FAERS
35Angina PectorisFAERS: 1US FAERS
36Animal biteFAERS: 1US FAERS
37AnxietyFAERS: 1US FAERS
38AsthmaFAERS: 1US FAERS
39Blood potassium increasedFAERS: 1US FAERS
40BronchitisFAERS: 1US FAERS
41CarcinomaFAERS: 1US FAERS
42CholelithiasisFAERS: 1US FAERS
43DehydrationFAERS: 1US FAERS
44Depressed Level of ConsciousnessFAERS: 1US FAERS
45DiplopiaFAERS: 1US FAERS
46Disease recurrenceFAERS: 1US FAERS
47DiverticulumFAERS: 1US FAERS
48Drug ineffectiveFAERS: 1US FAERS
49DyspepsiaFAERS: 1US FAERS
50Eating disorder symptomFAERS: 1US FAERS
51Erectile dysfunctionFAERS: 1US FAERS
52Feeling abnormalFAERS: 1US FAERS
53Foaming at mouthFAERS: 1US FAERS
54GastroenteritisFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
55GingivitisFAERS: 1US FAERS
56HeadacheFAERS: 1US FAERS
57HypersensitivityFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
58Hypertensive crisisFAERS: 1US FAERS
59HypotensionFAERS: 1US FAERS
60Incorrect dose administeredFAERS: 1US FAERS
61MalaiseFAERS: 1US FAERS
62Muscle SpasticityFAERS: 1US FAERS
63MyositisFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
64No reaction on previous exposure to drugFAERS: 1US FAERS
65PainFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
66PalpitationsFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
67Photosensitivity allergic reactionFAERS: 1US FAERS
68PsoriasisFAERS: 1US FAERS
69Renal Artery StenosisFAERS: 1US FAERS
70SinusitisFAERS: 1US FAERS
71SomnolenceFAERS: 1US FAERS
72SwellingFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
73TachycardiaFAERS: 1US FAERS
74ThrombocytopeniaFAERS: 1US FAERS
75Ventricular DysfunctionFAERS: 1US FAERS
76VertigoFAERS: 1US FAERS
77Viral myositisFAERS: 1US FAERS
78Weight decreasedFAERS: 1US FAERS
79Wrong drug administeredFAERS: 1US FAERS
80jaundiceFAERS: 1US FAERS
81Chest PainCanada Vigilance: 1Canada Vigilance
82Feeling ColdCanada Vigilance: 1Canada Vigilance
83Lip swellingCanada Vigilance: 1Canada Vigilance
84Muscle RigidityCanada Vigilance: 1Canada Vigilance
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120239

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.